Sun Pharmaceutical Industries Ltd.

The sales surged to Rs. 49328.80 millions, up 34.58% for the June 2022 quarter as against Rs. 36652.90 millions during the corresponding quarter previous year.The Total Profit for the quarter ended June 2022 of Rs. 10118.00 millions grew from Rs.-1382.80 millionsThe company reported a good operating profit of 14986.50 millions compared to 4550.30 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202206	202106	% Var	202206	202106	% Var	202203	202103	% Var
Sales	49328.80	36652.90	34.58	49328.80	36652.90	34.58	155859.80	141160.50	10.41
Other Income	1762.10	2116.90	-16.76	1762.10	2116.90	-16.76	11968.80	1920.70	523.15
PBIDT	14986.50	4550.30	229.35	14986.50	4550.30	229.35	38654.40	24490.80	57.83
Interest	870.70	1074.60	-18.97	870.70	1074.60	-18.97	3881.00	2675.20	45.07
PBDT	14115.80	1820.00	675.59	14115.80	1820.00	675.59	16568.10	20920.00	-20.80
Depreciation	3745.00	3069.30	22.01	3745.00	3069.30	22.01	13499.50	12364.30	9.18
PBT	10370.80	-1249.30	-930.13	10370.80	-1249.30	-930.13	3068.60	8555.70	-64.13
TAX	252.80	133.50	89.36	252.80	133.50	89.36	4068.50	131.70	2989.22
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	10118.00	-1382.80	-831.70	10118.00	-1382.80	-831.70	-999.90	8424.00	-111.87
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	30.38	12.41	144.72	30.38	12.41	144.72	24.80	17.35	42.95